MKS Inc. (NASDAQ:MKSI – Get Free Report) EVP Kathleen Flaherty Burke sold 4,355 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $319.94, for a total transaction of $1,393,338.70. Following the transaction, the executive vice president directly owned 49,439 shares of the company’s stock, valued at $15,817,513.66. This represents a 8.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
Kathleen Flaherty Burke also recently made the following trade(s):
- On Friday, February 20th, Kathleen Flaherty Burke sold 4,254 shares of MKS stock. The shares were sold at an average price of $250.00, for a total transaction of $1,063,500.00.
MKS Stock Down 4.0%
Shares of MKSI traded down $12.73 on Tuesday, hitting $306.98. 988,835 shares of the stock traded hands, compared to its average volume of 1,410,819. The company has a market capitalization of $20.73 billion, a PE ratio of 64.37, a P/E/G ratio of 1.62 and a beta of 1.98. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.70 and a current ratio of 1.11. The business has a 50 day simple moving average of $251.77 and a 200 day simple moving average of $208.07. MKS Inc. has a one year low of $80.22 and a one year high of $326.83.
Analyst Ratings Changes
Several equities research analysts recently weighed in on MKSI shares. Morgan Stanley reissued an “overweight” rating and set a $354.00 price target on shares of MKS in a research report on Thursday. Wall Street Zen raised shares of MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday. The Goldman Sachs Group reissued a “sell” rating and set a $265.00 price target on shares of MKS in a research report on Thursday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $380.00 target price on shares of MKS in a report on Friday. Finally, JPMorgan Chase & Co. lifted their target price on shares of MKS from $305.00 to $365.00 and gave the stock an “overweight” rating in a research report on Friday. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $317.23.
View Our Latest Analysis on MKS
Institutional Investors Weigh In On MKS
Large investors have recently added to or reduced their stakes in the stock. USA Financial Formulas bought a new stake in MKS in the 4th quarter worth approximately $26,000. Global Retirement Partners LLC grew its position in MKS by 560.0% in the 4th quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company’s stock worth $26,000 after purchasing an additional 140 shares during the period. IFP Advisors Inc grew its position in MKS by 616.7% in the 4th quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 148 shares during the period. Smartleaf Asset Management LLC grew its position in MKS by 74.5% in the 3rd quarter. Smartleaf Asset Management LLC now owns 260 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 111 shares during the period. Finally, Danske Bank A S purchased a new position in shares of MKS during the 3rd quarter worth $37,000. Institutional investors own 99.79% of the company’s stock.
About MKS
MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high?technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.
The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.
See Also
- Five stocks we like better than MKS
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.
